Gemcitabine (G) fixed-dose-rate infusion (FDR) plus erlotinib (E) in patients with advanced pancreatic cancer (APC).
Alberto Munoz Llarena
Disclosure not yet available
Joan Manel Mane
Disclosure not yet available
Guillermo Lopez-Vivanco
Disclosure not yet available
Abigail Ruiz de Lobera
Disclosure not yet available
Aintzane Sancho
Disclosure not yet available
Eluska Iruarrizaga
Disclosure not yet available
Mikel Arruti
Disclosure not yet available
Ines Marrodan
Disclosure not yet available
Natalia Fuente
Disclosure not yet available
David Ballesteros
Disclosure not yet available